Merck wins approval for cancer drug acquired in 2019 biotech buyout

Retrieved on: 2021-08-16 15:20:39

Tags for this article:

Click the tags to see associated articles and topics

Merck wins approval for cancer drug acquired in 2019 biotech buyout. View article details on hiswai:

Excerpt

BioPharma Dive Merck puts $1B more into oncology, with kidney cancer a focus offsite link. Follow Ned Pagliarulo on Twitter.

Article found on: www.biopharmadive.com